Uniphar (LON:UPR) Hits New 12-Month High - Here's What Happened

Uniphar plc (LON:UPR - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 260 ($3.46) and last traded at GBX 256.44 ($3.41), with a volume of 1024 shares trading hands. The stock had previously closed at GBX 254 ($3.38).

Analyst Upgrades and Downgrades

Separately, Shore Capital restated a "buy" rating on shares of Uniphar in a report on Tuesday, February 25th.

Uniphar Price Performance

The firm has a market capitalization of £798.25 million, a P/E ratio of 17.83 and a beta of 0.75. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48. The firm has a 50 day moving average price of GBX 229.12 and a 200-day moving average price of GBX 200.24.

Uniphar Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, May 16th. Shareholders of record on Thursday, April 24th will be given a dividend of €0.01 ($0.01) per share. This is a boost from Uniphar's previous dividend of $0.01. The ex-dividend date of this dividend is Thursday, April 24th. This represents a yield of 0.47%. Uniphar's payout ratio is 13.91%.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.